TY  - CHAP
M1  - Book, Section
TI  - Perioperative Management of Anticoagulants
A1  - Kaatz, Scott
A1  - Douketis, James D.
A2  - Cohn, Steven L.
Y1  - 2021
N1  - 
T2  - Decision Making in Perioperative Medicine: Clinical Pearls
AB  - It  is  estimated  that  6  million  patients  with  atrial  fibrillation  worldwide  will  require  anticoagulation  interruption  per  year  for  an  invasive  procedure,  or  about  one  in  six  patients  annually,1  and  this  number  is  increased  when  patients  with  mechanical  valves  and  venous  thromboembolism  (VTE)  are  included.  Periprocedural  interruption  of  anticoagulation  has  several  components:  a)  need  for  interruption;  b)  pre-procedure  interruption  timing;  c)  timing  of  post-procedure  resumption;  d)  need  for  parenteral  bridging  anticoagulation;  and  e)  urgent  reversal  for  emergent  procedures.  Four  primary  guidelines  help  inform  periprocedural  anticoagulation  interruption:  the  2012  American  College  of  Chest  Physicians  (ACCP)  guidelines,2  the  2017  American  College  of  Cardiology  (ACC)  Expert  Consensus  Decision  Pathway  which  offers  guidance  for  patients  with  atrial  fibrillation  only,3  the  2018  American  Society  of  Regional  Anesthesia  and  Pain  Medicine  (ASRA)  guidelines,4  and  the  2018  American  Society  of  Hematology  guidelines  for  VTE.5  
SN  - 
PB  - McGraw Hill
CY  - New York, NY
Y2  - 2024/04/20
UR  - accessmedicine.mhmedical.com/content.aspx?aid=1179530588
ER  -